Glycated hemoglobin measurements at three, 12 and 24 months postpartum after gestational diabetes

Area of Science:

• Reproductive health
• Endocrinology
• Diabetes management

Background:

• Gestational diabetes increases the risk of type 2 diabetes postpartum.
• Consistent monitoring of glycemic control is crucial for long-term health outcomes.
• Lifestyle interventions can impact postpartum metabolic health.

Purpose of the Study:

• To assess the associations between glycated hemoglobin (A1C) levels at 3, 12, and 24 months postpartum.
• To evaluate the reliability of repeated A1C measurements in the postpartum period.
• To inform diabetes management strategies for women with a history of gestational diabetes.

Main Methods:

• The Families Defeating Diabetes trial involved a 12-month postpartum lifestyle intervention.
• Participants were assessed at 3, 6, 12, and 24 months postpartum.
• Glycated hemoglobin (A1C) levels were measured at 3, 12, and 24 months.

Main Results:

• Intraclass correlation coefficients indicated substantial reliability between repeated A1C measures (0.74 for 3 vs. 12 months; 0.72 for 3 vs. 24 months).
• Pearson correlations further supported the consistency of A1C values over time (r=0.745 for 3 vs. 12 months).
• No significant differences in study outcomes were observed between the intervention and control groups.

Conclusions:

• Postpartum A1C measurements demonstrate significant reliability, suggesting their utility for tracking glycemic control.
• Consistent A1C levels over 24 months postpartum indicate the potential for stable metabolic status or the need for ongoing management.
• These findings support the use of A1C as a reliable biomarker in postpartum diabetes care and research.